sleep apnea semaglutide Tirzepatide and Semaglutide: Impact on OSA in Obesity VisualAbstract: Tirzepatide Improved Outcomes in

Regulate advertising to prevent misleading claims and misuse

doi: 10.1038/s41467-024-51062-w 187 SulijayaB.Yamada-HaraM.Yokoji-TakeuchiM.Matsuda-MatsukawaY.YamazakiK.MatsugishiA.et al

With 9,650 participants, this randomized, double-blind, placebo-controlled study robustly demonstrated that oral semaglutide reduces the incidence of MACEcomprising cardiovascular death, myocardial infarction, and strokeby 14% compared to placebo

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

Buying them separately allows the classic split (BPC-157 more frequent, TB-500 heavier and less often)

The trial enrolled 9,650 participants and showed a 14% reduction in MACE among those receiving oral semaglutide compared to a placebo, both alongside standard care